1. Home
  2. LICN vs ANVS Comparison

LICN vs ANVS Comparison

Compare LICN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LICN
  • ANVS
  • Stock Information
  • Founded
  • LICN 2004
  • ANVS 2008
  • Country
  • LICN China
  • ANVS United States
  • Employees
  • LICN N/A
  • ANVS N/A
  • Industry
  • LICN
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LICN
  • ANVS Health Care
  • Exchange
  • LICN Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • LICN 83.8M
  • ANVS 92.6M
  • IPO Year
  • LICN 2023
  • ANVS 2020
  • Fundamental
  • Price
  • LICN $0.15
  • ANVS $5.01
  • Analyst Decision
  • LICN
  • ANVS Strong Buy
  • Analyst Count
  • LICN 0
  • ANVS 6
  • Target Price
  • LICN N/A
  • ANVS $29.67
  • AVG Volume (30 Days)
  • LICN 20.0M
  • ANVS 488.6K
  • Earning Date
  • LICN 12-31-2024
  • ANVS 11-08-2024
  • Dividend Yield
  • LICN N/A
  • ANVS N/A
  • EPS Growth
  • LICN 36.90
  • ANVS N/A
  • EPS
  • LICN 0.28
  • ANVS N/A
  • Revenue
  • LICN $41,929,000.00
  • ANVS N/A
  • Revenue This Year
  • LICN N/A
  • ANVS N/A
  • Revenue Next Year
  • LICN N/A
  • ANVS N/A
  • P/E Ratio
  • LICN $0.55
  • ANVS N/A
  • Revenue Growth
  • LICN 24.86
  • ANVS N/A
  • 52 Week Low
  • LICN $0.13
  • ANVS $4.21
  • 52 Week High
  • LICN $2.44
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • LICN 24.70
  • ANVS 44.02
  • Support Level
  • LICN $0.13
  • ANVS $4.61
  • Resistance Level
  • LICN $0.17
  • ANVS $4.95
  • Average True Range (ATR)
  • LICN 0.02
  • ANVS 0.38
  • MACD
  • LICN 0.06
  • ANVS 0.07
  • Stochastic Oscillator
  • LICN 16.61
  • ANVS 40.40

About LICN Lichen China Limited

Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: